Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 28;8(4):195.
doi: 10.3390/tropicalmed8040195.

Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso

Jean Moïse Tanga Kaboré  1   2   3 , Mohamadou Siribié  1 , Denise Hien  1 , Issiaka Soulama  1   4 , Nouhoun Barry  1 , Adama Baguiya  4 , Alfred B Tiono  1 , Christian Burri  2   3 , André-Marie Tchouatieu  5 , Sodiomon B Sirima  1
Affiliations

Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso

Jean Moïse Tanga Kaboré et al. Trop Med Infect Dis. .

Abstract

(1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying multiple first-line therapies (MFT) may help mitigate this threat and extend the therapeutic life of current ACTs. (2) Methods: A district-wide pilot quasi-experimental study was conducted, deploying three different ACTs at the public health facility (PHF) level for uncomplicated malaria treatment from December 2019 to December 2020 in the health district (HD) of Kaya, Burkina Faso. Mixed methods, including household and health facility-based quantitative and qualitative surveys, were used to evaluate the pilot programme. (3) Results: A total of 2008 suspected malaria patients were surveyed at PHFs, of which 79.1% were tested by rapid diagnostic test (RDT) with 65.5% positivity rate. In total, 86.1% of the confirmed cases received the appropriate ACT according to the MFT strategy. The adherence level did not differ by study segment (p = 0.19). Overall, the compliance level of health workers (HWs) with MFT strategy was 72.7% (95% CI: 69.7-75.5). The odds of using PHF as the first source of care increased after the intervention (aOR = 1.6; 95% CI, 1.3-1.9), and the reported adherence to the 3-day treatment regimen was 82.1%; (95% CI: 79.6-84.3). Qualitative results showed a high acceptance of the MFT strategy with positive opinions from all stakeholders. (4) Conclusions: Implementing an MFT strategy is operationally feasible and acceptable by stakeholders in the health systems in Burkina Faso. This study provides evidence to support the simultaneous use of multiple first-line artemisinin combination therapies in malaria-endemic countries such as Burkina Faso.

Keywords: Burkina Faso; acceptability; feasibility; malaria; multiples first-line therapies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Possible options for deploying the MFT strategy.
Figure 2
Figure 2
Map of health facilities in the district of Kaya included in this pilot study, 2020.
Figure 3
Figure 3
Study drugs stock management.
See this image and copyright information in PMC

References

    1. World Health Organization . World Malaria Report 2022. World Health Organization; Geneva, Switzerland: 2022.
    1. Ministère de la Santé Secrétariat Général, Direction Générale des Etudes et des Statistiques Sectorielles, Burkina Faso. Annuaire Statistique 2020. [(accessed on 21 May 2022)]; Available online: https://www.sante.gov.bf/fileadmin/user_upload/storages/annuaire_statist....
    1. Trape J.F. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 2001;64((Suppl. 1–2)):12–17. doi: 10.4269/ajtmh.2001.64.12. - DOI - PubMed
    1. Global Partnership to Roll Back Malaria . World Health Organization; [(accessed on 14 February 2023)]. Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation, 4–5 April 2001. Available online: https://apps.who.int/iris/handle/10665/66952.
    1. Rasmussen C., Alonso P., Ringwald P. Current and emerging strategies to combat antimalarial resistance. Expert. Rev. Anti. Infect. Ther. 2022;20:353–372. doi: 10.1080/14787210.2021.1962291. - DOI - PubMed

LinkOut - more resources